Iconic Therapeutics fetches $40 mln Series C

By Iris Dorbian — 1 month ago

Iconic Therapeutics, a biopharmaceutical company focused on serious eye disorders, has raised $40 million in Series C funding. The investors included HBM Healthcare Investments, Cormorant Asset Management, Osage University Partners, MPM Capital, H.I.G. Capital and Lundbeckfund Ventures.

Continue

Kymeta grabs $62 mln Series D

By Iris Dorbian — 1 month ago

Redmond, Washington-based Kymeta Corp, a smart antenna developer, has secured $62 million in Series D funding. The investors included return backers Bill Gates, Lux Capital, Kresge Foundation and Osage University Partners.

Continue

Millendo Therapeutics snags $62 mln Series B

By Iris Dorbian — 1 month ago

Ann Arbor, Michigan-based Millendo Therapeutics (formerly known as Atterocor Inc), a biopharmaceutical company focused on treating orphan and specialty endocrine diseases, has raised $62 million in Series B funding. New Enterprise Associates Inc led the round. Other investors included Roche Venture Fund, Adams Street Partners, Altitude Life Science Ventures, Longwood Fund, Renaissance Venture Capital Fund, Frazier Healthcare Partners, Osage University Partners and 5AM Ventures.

Continue

PsiKick raises $16.5 mln

By Luisa Beltran — 2 months ago

PsiKick said Wednesday that it raised $16.5 million in Series B financing led by Osage University Partners. Also participating were existing investors New Enterprise Associates, the University of Michigan Investment in New Technologies Fund (MINTS), as well as individual angels. PsiKick, of Santa Clara, California, is developing wireless, self-powering Internet of Things systems.

Continue

eFFECTOR Therapeutics nabs $40 mln Series B

By Iris Dorbian — 2 months ago

San Diego-based eFFECTOR Therapeutics, a biopharmaceutical company focused on treating cancer, has raised $40 million in Series B funding. The investors were Altitude Life Science Ventures, AbbVie Biotech Ventures, BioMed Ventures, Abingworth, Novartis Venture Fund, SR One, The Column Group, US Venture Partners, Astellas Ventures, Osage University Partners and Mission Bay Capital. In addition to the funding, eFFECTOR has named Dave Maki, managing partner of Altitude Life Science Ventures, to its board of directors.

Continue

VC-backed Mirna Therapeutics debuts IPO

By Iris Dorbian — 4 months ago

Austin, Texas-based Mirna Therapeutics Inc, a biopharmaceutical company focused on developing cancer-treating drugs, has raised almost $44 million for its IPO after pricing its 6.25 million shares at $7 per share. The stock began trading Thursday on the NASDAQ under the ticker symbol “MIRN.” Citigroup and Leerink Partners are the lead underwriters. Mirna’s backers included Sofinnova Ventures, New Enterprise Associates, Pfizer Ventures, Osage University Partners and Correlation Ventures.

Continue

PeopleLinx reels in $3.5 mln

By Iris Dorbian — 6 months ago

Philadelphia-based PeopleLinx, which provides solutions that improve buyer engagement, has raised $3.5 million in funding. The investors were Osage Venture Partners, Greycroft Partners and MissionOG.

Continue

Osage University Partners adds to team

By Iris Dorbian — 6 months ago

Osage University Partners has hired Kirsten Leute as senior vice president of university relations. Previously, Leute worked at Stanford University where she served as an associate director of the office of technology licensing.

Continue

Picwell snaps up more than $4 mln Series A

By Iris Dorbian — 7 months ago

Picwell, a predictive recommendation engine provider for health plan section, has secured more than $4 million in Series A funding. MassMutual Ventures led the round with participation from other investors that included Osage University Partners.

Continue

Menlo Security attracts $25 mln Series B

By Iris Dorbian — 8 months ago

Menlo Park, California-based Menlo Security, a cyber security company that has launched from stealth mode, has raised $25 million in Series B funding. Sutter Hill Ventures led the round with participation from return backers General Catalyst, Osage University Partners and Engineering Capital.

Continue

Clarifai nets $10 mln Series A

By Iris Dorbian — 10 months ago

New York City-based Clarifai, a provider of image recognition technology, has raised an overall total of $10 million in Series A funding, the company announced in a blog post on its site. Union Square Ventures, Lux Capital and Osage University Partners led the round with participation from Google Ventures, Qualcomm Ventures, Nvidia Ventures, Corazon Capital, LDV Capital and New York University.

 

Continue

Seismos pulls in $4 mln

By Iris Dorbian — 10 months ago

Austin, Texas-based Seismos Inc, a provider of real-time subsurface fluid flow monitoring for oil and gas production optimization, has received about $4 million in funding. Javelin Venture Partners led the round with participation from other investors that included Osage University Partners. Also, Noah Doyle, a general partner at Javelin Venture Partners, has been added to the Seismos board of directors.

Continue

Merganser Biotech snags $28 mln Series A

By Iris Dorbian — 12 months ago

Merganser Biotech Inc, which focuses on treating rare blood and iron-related diseases, has secured $28 million in Series A financing. Novartis Venture Fund led the round with participation from Frazier Healthcare, Sutter Hill Ventures, Osage University Partners, BioAdvance and Stateside Developments. In addition to the funding, Markus Goebel of Novartis Venture Fund, James Topper of Frazier Healthcare and Jeffrey Bird of Sutter Hill Ventures have been added to Merganser’s board of directors. Also, Bill Harrington of Osage University Partners has been named as a board observer.

Continue

PMV Pharmaceuticals grabs $30 mln

By Iris Dorbian — 1 year ago

PMV Pharmaceuticals, which develops p53 targeted small molecule drugs to treat cancer, has raised $30 million in Series A financing. OrbiMed led the round with participation from Osage University Partners and supported by founding investor InterWest Partners. In addition to the funding, Dr. Peter Thompson of OrbiMed has been appointed to PMV’s board of directors.

Continue

Menlo Security attracts $10.5 mln Series A

By Iris Dorbian — 1 year ago

Menlo Park, Calif.-based Menlo Security, a stealth cyber security start-up, has secured $10.5 million in Series A funding. General Catalyst Partners led the round with participation from Osage University Partners. In conjunction with the funding, Steve Herrod, a managing director at General Catalyst, has been added to Menlo Security’s board.

Continue

3D firm Paracosm attracts $3.3 mln seed

By Iris Dorbian — 1 year ago

3D firm Paracosm has closed $3.3 million in seed funding. Atlas Venture led the round with participation from other investors that included iRobot, Osage University Partners, BOLDstart Ventures, New World Angels and Deep Fork Capital.

Continue

Liquid Light closes $15 mln Series B funding round

By Chris Witkowsky — 1 year ago

Liquid Light, which develops and licenses process technology to make major chemicals from carbon dioxide, has raised a $15 million Series B funding round. New investors in the funding include Sustainable Conversion Ventures. Existing investors include VantagePoint Capital Partners, BP Ventures, Chrysalix Energy Venture Capital and Osage University Partners.

Continue